Tilray Brands expanded its global medical cannabis cultivation. The company increased its total annual production capacity by over 30%. This expansion brings total capacity to approximately 275 metric tonnes.
Increased output at facilities in Quebec, Canada, and its EU-GMP-certified site in Portugal drives this growth.
The expansion responds to accelerating international demand for medical cannabis.
The Quebec facility added 30 metric tonnes of annual capacity. This will supply the local market, Europe, and Australia.
Increased production in Portugal will bolster the supply chain to key European markets. These markets include Germany and the United Kingdom.